Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  K. Tizaoui.  Multiple sclerosis genetics: Results from meta‐analyses of candidate‐gene association studies , 2017, Cytokine.

[3]  A. Hamzaoui,et al.  Update on Asthma Genetics: Results From Meta-Analyses of Candidate Gene Association Studies. , 2018, Current molecular medicine.

[4]  Lisa J. Martin,et al.  OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children. , 2017, Pharmacogenomics.

[5]  J. Kere,et al.  Investigation of rare and low-frequency variants using high-throughput sequencing with pooled DNA samples , 2016, Scientific Reports.

[6]  J. Kere,et al.  Exome sequencing in pooled DNA samples to identify maternal pre-eclampsia risk variants , 2016, Scientific Reports.

[7]  S. Kaasa,et al.  Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  J. Potash,et al.  Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. , 2016, Cancer discovery.

[9]  C. C. van der Rijt,et al.  A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures. , 2015, The journal of pain : official journal of the American Pain Society.

[10]  Jing He,et al.  Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation , 2015, Nature Genetics.

[11]  Lin Lu,et al.  The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. , 2015, Pain physician.

[12]  K. Kaufman,et al.  Novel Associations between FAAH Genetic Variants and Postoperative Central Opioid related Adverse Effects , 2014, The Pharmacogenomics Journal.

[13]  S. Sugino,et al.  Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting , 2014, Experimental Brain Research.

[14]  Michiaki Kubo,et al.  Genome-Wide Association Study: A Useful Tool to Identify Common Genetic Variants Associated with Drug Toxicity and Efficacy in Cancer Pharmacogenomics , 2014, Clinical Cancer Research.

[15]  S. Redaelli,et al.  CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data , 2013, PloS one.

[16]  Roberta Spinelli,et al.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia , 2012, Nature Genetics.

[17]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[18]  P. Stone,et al.  Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. , 2012, The Lancet. Oncology.

[19]  S. Kaasa,et al.  Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study , 2011, European Journal of Clinical Pharmacology.

[20]  P. Fayers,et al.  Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids. , 2011, European journal of cancer.

[21]  Cinzia Brunelli,et al.  Multiple Loci Modulate Opioid Therapy Response for Cancer Pain , 2011, Clinical Cancer Research.

[22]  S. Kaasa,et al.  Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Corbin,et al.  Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. , 2011, Physiological reviews.

[24]  Anne Kari Knudsenl,et al.  Which variables are associated with pain intensity and treatment response in advanced cancer patients?— Implications for a future classification system for cancer pain , 2011 .

[25]  P. Fayers,et al.  Which variables are associated with pain intensity and treatment response in advanced cancer patients?— Implications for a future classification system for cancer pain , 2011, European journal of pain.

[26]  John P. Rice,et al.  Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans , 2010, Genes, brain, and behavior.

[27]  John P A Ioannidis,et al.  Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. , 2010, Trends in genetics : TIG.

[28]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[29]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[30]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[31]  E. Voest,et al.  Symptom prevalence in patients with incurable cancer: a systematic review. , 2007, Journal of Pain and Symptom Management.

[32]  S. Kaasa,et al.  Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network , 2005, Palliative medicine.

[33]  H. Amrein,et al.  Bitter-Sweet Solution in Taste Transduction , 2003, Cell.

[34]  P. Fayers,et al.  A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. , 2000, European journal of cancer.

[35]  V. Thomas.  Cancer pain relief, 2nd Edn: WHO, Geneva. £11.90, ISBN 92 4 154482 1 , 1997 .

[36]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[37]  F. De Conno,et al.  A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.